Steven G. Gray
0000-0002-5850-6392
Publication & Citation Trends
Publications
0 total
Abstract C058: ADORA2B Inhibition in Mesothelioma (MMe) cells affects PDL-1 expression, exerts an effective response on Hyppo and AKT signaling and elicits anti-tumor immune response
Cited by 0
Semantic Scholar
247P: The adenosine pathway is an actionable multitarget for mesothelioma (MMe)
Cited by 0
Semantic Scholar
Reducing pERKs to Break "RAS"istance to Sotorasib.
Cited by 1
Semantic Scholar
"WEE"ding Out Resistance to Osimertinib in the "ARID"1A-Mutated Badlands.
Cited by 0
Semantic Scholar
Based on the Real-World Results From Australia, Immunotherapy Is Not a Good Option for Patients With Mesothelioma. OA
Cited by 16
Semantic Scholar
Encouraging Fussy Eaters in EGFR-Mutated Lung Cancer.
Cited by 0
Semantic Scholar
Research Topics
Histone Deacetylase Inhibitors Research
(52)
Epigenetics and DNA Methylation
(50)
Occupational and environmental lung diseases
(50)
Lung Cancer Treatments and Mutations
(32)
MicroRNA in disease regulation
(29)
Affiliations
University College Dublin
University of Iowa
Brigham and Women's Hospital
Trinity Health
Van Andel Institute